Home

AddThis

Print

email this

New in Neurosurgery

 

CBS News and 60 Minutes Highlight Duke Brain Tumor Therapy
 

  • CBS News: How the polio virus is being used to fight cancer
  • 60 Minutes (full segments to air March 29): 60 Minutes follows brain cancer patients at Duke University in the first clinical trial, two of whom now show no signs of cancer

 

Dr. John Sampson was interviewed by several major news outlets about his, and many other Duke authors, Nature article detailing the benefits of tetanus toxoid injections to the dendritic CMV vaccine therapy of patients with GBM.

Related Links

Dr. John Sampson has been named the recipient of the 2015 Abhijit Guha Award by the Society for Neuro-Oncology and the AANS/CNS Section on Tumors. The award honors an accomplished investigator who has achieved significant results both in the laboratory and the clinic, and has actively mentored the next generation of neuro-oncology professionals.

Fernando Gonzalez and Ali Zomorodi conduct the recent endovascular Flow Diversion Course. The inaugural course attracted attendees from as far away as Japan to learn about this new technique. Read all about it here.


Read a new article in the Journal of Neurochemistry by Dr. Darrell Bigner, Dr. John SampsonDr. Francis Ali-Osman, and colleagues: "Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: Implications for drug development."

Kudos to Dr. Stephen Keir, who received a grant from Merk KGaA for “Evaluation of c-Met Inhibition in Brain Tumors.”

 

Congratulations to Dr. Nandan Lad, who was awarded a grant from Medtronic Inc. for “Prospective, Randomized Study of Multicolumn Implantable Lead Stimulation for Predominant Low Back Pain.” Dr. Lad also recently participated in a recent study of 1,757 patients which found that older Parkinson's patients have no higher risk for complications after surgery to implant deep brain stimulation devices.

Duke neurosurgeon Ali Zomorodi performs endoscopic surgery to remove a teenager's pituitary tumor and restore her vision.


Immunotherapy is the subject of Dr. John Sampson's new interview with the National Brain Tumor Society

Kudos to Dr. Carlos Bagley, who was awarded a grant from Integra LifeSciences for “DuraSeal Exact Spine Sealant System Post-Approval Study.”

 

In a new webcast, Duke neurosurgeon John Sampson and radiation oncologist John Kirkpatrick discuss the various metastatic brain tumor treatments available today. Their conversation spans the benefits, limitations, and indications for surgery, stereotactic radiosurgery, and whole-brain radiation therapy, as well as patient characteristics that affect treatment selection.

From OR to writers' room: spine surgeon Oren Gottfried's profile in Duke Today reveals a complex character.

 

“Oncolytic Poliovirus Therapy of Malignant Glioma” earned Dr. Matthias Gromeier a grant from the Southeastern Brain Tumor Foundation.

 

See all news.

@DukeNeurosurg 

Follow @DukeNeurosurg on Twitter

 

Publications

Innovation and Opportunity: Duke Neurosurgery Residency Program The Duke Neurosurgery Residency Program is a seven-year program that offers three positions annually. For 2015 the program has been extensively augmented and reimagined to maximize learning potential in a collaborative environment that optimizes patient care. See what's new in our Innovation and Opportunity issue (PDF).

A new video offers an in-depth look into the  Duke Neurosurgery Residency Program by those who recently reinvented it. 

 

 

 

Patient Care

Patient Care Services
Visit dukemedicine.org for information about patient care services offered by Duke Medicine.

Clinical Advice
Contact the Duke Consultation and Referral Center to obtain access to clinical advice via appointment or physician practice triage nurse:
888-ASK-DUKE (888-275-3853) or
919-416-DUKE (919-416-3853)

Referring Physicians
Visit the Duke Medicine Referring Physicians page.